Search results
Showing 8086 to 8100 of 8140 results
How is NICE supporting digital health technology developers?
Richard Chivers, operations manager for NICE Scientific Advice, looks at how we’re supporting digital health technology developers and helping them with some of the challenges around evidence requirements and adoption within the NHS.
How my experience as a patient helped shape NICE guidelines for colorectal cancer
Following my surgery and treatment for colorectal cancer in 2014, I wanted to contribute to research in the cancer field and hopefully improve things for patients in the future, so I applied and was accepted to be a lay member for NICE’s colorectal cancer guideline committee.
How NICE guidance and resources can be used to evidence continuing professional development (CPD)
Registered social workers must demonstrate the use of evidence and research to inform their practice in order to meet professional standards. This is echoed in Social Work England’s continuing professional development (CPD) standards.
How NICE is helping to build the role of the NHS on the global stage
Kevin Miles discusses how NICE International is working to shape and improve health and care systems at home and abroad as part of the NHS Consortium for Global Health.
Working at the forefront of neurodegenerative disease research
Claire Hawksworth reveals NICE’s role in a global partnership to better understand neurodegenerative conditions and speed up delivery of innovative treatments.
Working in partnership to harness the potential of digital technology
Nicola Bent talks about NICE and the AHSN Network’s important ambition to address market access challenges for digital innovation as part of the collaboration agreement
Nick discusses World Antimicrobial Awareness Week and an important project he’s involved with to develop new models for the evaluation and purchase of antimicrobials.
World Evidence-Based Healthcare Day: Using evidence to inform our recommendations
Dr Martin Allaby discusses World Evidence-Based Healthcare Day and how NICE uses evidence to inform our recommendations.
Dalia Dawoud, Scientific Adviser at NICE Science, Evidence and Analytics Directorate explains NICE’s role as co-host of HTAi 2021 in the UK
Draft guidance released for consultation today (Friday 4th Nov) states the technologies can be used with support from a mental health professional, while further evidence is generated to check if the benefits they offer are realised in practice.
Behind the Headlines - Prostate cancer drug decision a 'cruel twist'
We take a closer look at media coverage that claims our prostate cancer drug decision is a 'cruel twist' for patients.
NICE recommends adapted shoes for people with severe osteoarthritis
People with osteoarthritis who are eligible for knee surgery could be offered specially adapted shoes to help with their painful and stiff knees following a draft recommendation by NICE.
Experts estimate that 450 to 500 people could be treated using FMT for multiple recurrences of C. diff infections each year.
NICE is advising doctors, nurses and pharmacists to discuss with patients the risks of prescribing them medicines including opioids, sleeping pills and antidepressants.
Explore data about our technology appraisal guidance. Find out about the decisions we make and our ways of working.